ID   1A68_HUMAN     STANDARD;      PRT;   365 AA.
AC   P01891; O19673; O19695; O19794; O19795; O43907; O77938; O98010;
AC   P10315; P79505; Q9MYA5; Q9MYC4; Q9TQG7; Q9TQN5; Q9UIN2;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   21-FEB-2001, sequence version 4.
DT   05-SEP-2006, entry version 74.
DE   HLA class I histocompatibility antigen, A-68 alpha chain precursor
DE   (MHC class I antigen A*68) (Aw-68) (A-28).
GN   Name=HLA-A; Synonyms=HLAA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*6802).
RX   MEDLINE=87252273; PubMed=3496393;
RA   Holmes N., Ennis P., Wan A.M., Denney D.W., Parham P.;
RT   "Multiple genetic mechanisms have contributed to the generation of the
RT   HLA-A2/A28 family of class I MHC molecules.";
RL   J. Immunol. 139:936-941(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*6802).
RA   Domena J.D.;
RL   Submitted (NOV-1993) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*6803).
RX   MEDLINE=97045039; PubMed=8881043; DOI=10.1007/s002510050172;
RA   Ellexson M., Lau M., Terasaki P., Hildebrand W.H.;
RT   "Molecular characterization of HLA-A*6803.";
RL   Immunogenetics 45:78-79(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*6808).
RX   MEDLINE=99321037; PubMed=10395114;
RX   DOI=10.1034/j.1399-0039.1999.530614.x;
RA   Cox S.T., Arguello J.R., Marsh S.G.E., Boham E., Lau M., Kwan P.L.,
RA   Madrigal J.A., Little A.-M.;
RT   "Sequence of HLA-A*6808.";
RL   Tissue Antigens 53:597-600(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*68011).
RC   TISSUE=Blood;
RA   Cox S.T.;
RT   "Confirmation of HLA-A*68011.";
RL   Submitted (JUN-2001) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*6817).
RX   MEDLINE=20340076; PubMed=10885567;
RX   DOI=10.1034/j.1399-0039.2000.550509.x;
RA   Ramon D., Scott I., Cox S.T., Pesoa S., Vullo C., Little A.M.,
RA   Madrigal J.A.;
RT   "HLA-A*6817, identified in the Kolla Amerindians of north-west
RT   Argentina possesses a novel nucleotide substitution.";
RL   Tissue Antigens 55:453-454(2000).
RN   [7]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*6806).
RA   Bei M., Hurley C.K.;
RL   Submitted (FEB-1997) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*6803).
RC   TISSUE=Blood;
RX   MEDLINE=97419180; PubMed=9271640; DOI=10.1007/s002510050304;
RA   Vargas-Alarcon G., Martinez-Laso J., Gomez-Casado E., Perez-Blas M.,
RA   Granados J., Alegre R., Alvarez M., Zuniga J., Arnaiz-Villena A.;
RT   "Description of HLA-A*6803 and A*68N in Mazatecan Indians from
RT   Mexico.";
RL   Immunogenetics 46:446-447(1997).
RN   [9]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*6803).
RC   TISSUE=Blood;
RA   Blasczyk R.;
RL   Submitted (AUG-1997) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*6802).
RA   Edson S.M., Hurley C.K.;
RL   Submitted (MAR-1999) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELES A*6809 AND A*6810).
RX   MEDLINE=20309230; PubMed=10852390;
RX   DOI=10.1034/j.1399-0039.2000.550412.x;
RA   Ellis J., Steiner N.K., Kosman C., Henson V., Mitton W., Koester R.,
RA   Ng J., Hartzman R.J., Hurley C.K.;
RT   "Seventeen more novel HLA-A locus alleles.";
RL   Tissue Antigens 55:369-373(2000).
RN   [12]
RP   NUCLEOTIDE SEQUENCE OF 3-206 (ALLELE A*6816).
RX   MEDLINE=20260982; PubMed=10803837; DOI=10.1007/s002510050618;
RA   Gomez-Casado E., Martinez-Laso J., Gonzalez-Hevilla M., Longas J.,
RA   Rubio I., Silvera-Redondo C., Garcia-Gomez A., Lowy E.,
RA   Arnaiz-Villena A.;
RT   "A novel HLA-A*6816 allele possible generated by a point mutation in a
RT   Chilean from Punta Arenas (Magellan Strait).";
RL   Immunogenetics 51:257-260(2000).
RN   [13]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELES A*6807 AND A*6817).
RX   MEDLINE=21160440; PubMed=11260503;
RX   DOI=10.1034/j.1399-0039.2001.057002095.x;
RA   Hickman H.D., Cavett J.W., Ellexson-Turner M.E., Sparkman J.N.,
RA   Bennett T.T., Turner S., Sidebottom D.A., Trachtenberg E.A.,
RA   Confer D.L., Hildebrand W.H.;
RT   "Non-conservative substitutions distinguish previously uncharacterized
RT   HLA-A molecules.";
RL   Tissue Antigens 57:95-102(2001).
RN   [14]
RP   NUCLEOTIDE SEQUENCE OF 26-297 (ALLELE A*6801).
RX   MEDLINE=86055720; PubMed=3877632;
RA   Holmes N., Parham P.;
RT   "Exon shuffling in vivo can generate novel HLA class I molecules.";
RL   EMBO J. 4:2849-2854(1985).
RN   [15]
RP   PARTIAL PROTEIN SEQUENCE OF 25-294 (A*6801).
RX   MEDLINE=82247941; PubMed=6179086;
RA   Lopez de Castro J.A., Strominger J.L., Strong D.M., Orr H.T.;
RT   "Structure of crossreactive human histocompatibility antigens HLA-A28
RT   and HLA-A2: possible implications for the generation of HLA
RT   polymorphism.";
RL   Proc. Natl. Acad. Sci. U.S.A. 79:3813-3817(1982).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 25-294 (A*6801).
RX   MEDLINE=93078854; PubMed=1448153; DOI=10.1038/360364a0;
RA   Guo H.-C., Jardetzky T.S., Garrett T.P.J., Lane W.S., Strominger J.L.,
RA   Wiley D.C.;
RT   "Different length peptides bind to HLA-Aw68 similarly at their ends
RT   but bulge out in the middle.";
RL   Nature 360:364-366(1992).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 25-294 (A*6801).
RX   MEDLINE=93078855; PubMed=1448154; DOI=10.1038/360367a0;
RA   Silver M.L., Guo H.-C., Strominger J.L., Wiley D.C.;
RT   "Atomic structure of a human MHC molecule presenting an influenza
RT   virus peptide.";
RL   Nature 360:367-369(1992).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 25-199 (A*6801).
RX   MEDLINE=95166800; PubMed=7862664;
RA   Collins E.J., Garboczi D.N., Karpusas M.N., Wiley D.C.;
RT   "The three-dimensional structure of a class I major histocompatibility
RT   complex molecule missing the alpha 3 domain of the heavy chain.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:1218-1221(1995).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC   -!- POLYMORPHISM: The following alleles of A-68 are known: A*6801
CC       (Aw68.1), A*6802, A*6803. A*6804, A*6805, A*6806, A*6807, A*6808,
CC       A*6809, A*6810, A*6816 and A*6817. The sequence shown is that of
CC       A*6801.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U03861; AAA03602.1; -; Unassigned_DNA.
DR   EMBL; X03070; CAB56605.1; -; Genomic_DNA.
DR   EMBL; X03071; CAB56606.1; -; Genomic_DNA.
DR   EMBL; U41057; AAB41292.1; -; mRNA.
DR   EMBL; AJ315642; CAC44382.1; -; Genomic_DNA.
DR   EMBL; AF144013; AAF74211.1; -; Genomic_DNA.
DR   EMBL; AJ245567; CAB59722.1; -; Genomic_DNA.
DR   EMBL; U91628; AAB50567.1; -; Genomic_DNA.
DR   EMBL; U91627; AAB50567.1; JOINED; Genomic_DNA.
DR   EMBL; U89946; AAB82079.1; -; Genomic_DNA.
DR   EMBL; U89947; AAB82080.1; -; Genomic_DNA.
DR   EMBL; AJ001274; CAA04647.1; -; mRNA.
DR   EMBL; AF072770; AAC25782.1; -; Genomic_DNA.
DR   EMBL; AF072769; AAC25782.1; JOINED; Genomic_DNA.
DR   EMBL; AF135545; AAD22270.1; -; Genomic_DNA.
DR   EMBL; AF135544; AAD22270.1; JOINED; Genomic_DNA.
DR   EMBL; AF108431; AAD27539.1; -; Genomic_DNA.
DR   EMBL; AF108430; AAD27539.1; JOINED; Genomic_DNA.
DR   EMBL; AJ223972; CAA11708.1; -; Genomic_DNA.
DR   EMBL; AF041372; AAD02208.1; -; Genomic_DNA.
DR   EMBL; AF041371; AAD02208.1; JOINED; Genomic_DNA.
DR   EMBL; AF268398; AAF73477.1; -; Genomic_DNA.
DR   EMBL; AF268397; AAF73477.1; JOINED; Genomic_DNA.
DR   PDB; 1HSB; X-ray; A=25-294.
DR   PDB; 1TMC; X-ray; A=25-199.
DR   PDB; 2HLA; X-ray; A=25-294.
DR   Ensembl; ENSG00000197499; Homo sapiens.
DR   HGNC; HGNC:4931; HLA-A.
DR   MIM; 142800; gene.
DR   LinkHub; P01891; -.
DR   ArrayExpress; P01891; -.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR003006; Ig_MHC.
DR   InterPro; IPR001039; MHC_I_alpha_A1A2.
DR   InterPro; IPR010579; MHC_I_alpha_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   ProDom; PD000050; MHC_I; 1.
DR   SMART; SM00407; IGc1; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
KW   3D-structure; Direct protein sequencing; Glycoprotein;
KW   Host-virus interaction; Immune response; Membrane; MHC I;
KW   Polymorphism; Signal; Transmembrane; Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    365       HLA class I histocompatibility antigen,
FT                                A-68 alpha chain.
FT                                /FTId=PRO_0000018830.
FT   TOPO_DOM     25    308       Extracellular (Potential).
FT   TRANSMEM    309    332       Potential.
FT   TOPO_DOM    333    365       Cytoplasmic (Potential).
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   CARBOHYD    110    110       N-linked (GlcNAc...).
FT   DISULFID    125    188
FT   DISULFID    227    283
FT   VARIANT      36     36       V -> M (in allele A*6802).
FT                                /FTId=VAR_004389.
FT   VARIANT      86     87       RN -> EE (in allele A*6810).
FT                                /FTId=VAR_010362.
FT   VARIANT      94     94       Q -> H (in allele A*6803, allele A*6804
FT                                and allele A*6805).
FT                                /FTId=VAR_010363.
FT   VARIANT      97     97       T -> I (in allele A*6804).
FT                                /FTId=VAR_010364.
FT   VARIANT      98     98       D -> H (in allele A*6805).
FT                                /FTId=VAR_010365.
FT   VARIANT     121    121       M -> R (in allele A*6802).
FT                                /FTId=VAR_004390.
FT   VARIANT     129    129       S -> P (in allele A*6802).
FT                                /FTId=VAR_004391.
FT   VARIANT     138    138       R -> E (in allele A*6806; requires 2
FT                                nucleotide substitutions).
FT                                /FTId=VAR_010366.
FT   VARIANT     138    138       R -> H (in allele A*6802).
FT                                /FTId=VAR_004392.
FT   VARIANT     140    140       D -> H (in allele A*6806 and allele
FT                                A*6807).
FT                                /FTId=VAR_010367.
FT   VARIANT     140    140       D -> V (in allele A*6817).
FT                                /FTId=VAR_010368.
FT   VARIANT     140    140       D -> Y (in allele A*6802).
FT                                /FTId=VAR_004393.
FT   VARIANT     175    175       H -> L (in allele A*6816).
FT                                /FTId=VAR_010369.
FT   VARIANT     180    180       W -> L (in allele A*6808).
FT                                /FTId=VAR_010370.
FT   VARIANT     180    180       W -> Q (in allele A*6809; requires 2
FT                                nucleotide substitutions).
FT                                /FTId=VAR_010371.
FT   CONFLICT    206    206       T -> A (in Ref. 12).
FT   CONFLICT    231    231       S -> G (in Ref. 15).
FT   STRAND       27     36
FT   TURN         39     40
FT   STRAND       41     43
FT   STRAND       45     52
FT   TURN         53     54
FT   STRAND       55     61
FT   TURN         62     63
FT   STRAND       64     66
FT   STRAND       68     68
FT   STRAND       70     71
FT   STRAND       73     73
FT   HELIX        74     76
FT   TURN         77     78
FT   HELIX        81    108
FT   TURN        109    110
FT   TURN        113    114
FT   STRAND      115    115
FT   STRAND      118    127
FT   TURN        129    130
FT   STRAND      131    131
FT   STRAND      133    142
FT   TURN        143    144
FT   STRAND      145    150
FT   TURN        152    153
FT   STRAND      154    155
FT   STRAND      157    161
FT   HELIX       162    173
FT   TURN        174    175
FT   HELIX       176    185
FT   TURN        186    186
FT   HELIX       187    198
FT   TURN        199    199
FT   HELIX       200    203
FT   TURN        204    204
FT   STRAND      207    207
FT   STRAND      210    235
FT   STRAND      238    243
FT   TURN        244    245
FT   STRAND      246    248
FT   TURN        250    251
FT   STRAND      252    254
FT   STRAND      258    259
FT   STRAND      261    263
FT   STRAND      265    274
FT   TURN        275    276
FT   HELIX       278    280
FT   STRAND      281    286
FT   TURN        288    289
FT   STRAND      290    292
SQ   SEQUENCE   365 AA;  40909 MW;  78539C59DB8B1DFC CRC64;
     MAVMAPRTLV LLLSGALALT QTWAGSHSMR YFYTSVSRPG RGEPRFIAVG YVDDTQFVRF
     DSDAASQRME PRAPWIEQEG PEYWDRNTRN VKAQSQTDRV DLGTLRGYYN QSEAGSHTIQ
     MMYGCDVGSD GRFLRGYRQD AYDGKDYIAL KEDLRSWTAA DMAAQTTKHK WEAAHVAEQW
     RAYLEGTCVE WLRRYLENGK ETLQRTDAPK THMTHHAVSD HEATLRCWAL SFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDGTFQKWVA VVVPSGQEQR YTCHVQHEGL PKPLTLRWEP
     SSQPTIPIVG IIAGLVLFGA VITGAVVAAV MWRRKSSDRK GGSYSQAASS DSAQGSDVSL
     TACKV
//
